Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Macrolide Antibiotics Market Expected to Grow Between 2025 And 2029?
The market size for macrolide antibiotics has seen quick expansion in the recent past. This sector is projected to escalate from $59.07 billion in 2024 to $65.42 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.8%. The growth noted during the historic period is a result of rising antibiotic resistance, sanctioning of new formulations, increasing incidences of infectious diseases, and initiatives by the government and healthcare sector.
In the coming years, the macrolide antibiotics market is projected to experience a rapid expansion, reaching a size of$97.96 billion by 2029″ with an annual growth rate (CAGR) of 10.6%. This anticipated growth over the forecast period can be linked to an increase in respiratory infections, a rise in combination therapies, a surge in the ageing population worldwide, heightened awareness and enhanced diagnostics, and the expansion of telemedicine and online pharmacy services. Key trends for the forecast period comprise advances in drug delivery systems and formulations, the creation of new macrolide antibiotics, improvements in telemedicine and remote healthcare services, and the introduction of environmentally friendly production processes for macrolide antibiotics.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16472&type=smp
What Are the Core Growth Drivers Propelling the Macrolide Antibiotics Market Forward?
The macrolide antibiotics market is likely to expand due to the rising incidence of skin infections. Skin infections, characterized by symptoms such as redness, swelling, and pain, result from the entrance of detrimental germs into the skin, causing inflammation. These infections often occur due to improper hygiene, weakened immune systems, exposure to pollutants, resistance to antibiotics, and insufficient wound care. Physicians often prescribe macrolide antibiotics to treat bacterial skin infections, specifically those resulting from Staphylococcus aureus or Streptococcus pyogenes, particularly when there’s an allergy or resistance to penicillin. For instance, per the UK Health Security Agency (UKHSA), in September 2022, there was an increase in Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia cases linked to skin and soft tissue infections, from 25.7% in the fiscal year April 2020-March 2021 to 33.7% in the fiscal year April 2021-March 2022. In addition, for Methicillin-Sensitive Staphylococcus aureus (MSSA) bacteremia cases, the percentage rose from 27.2% to 28.5% over the identical period. Thus, the escalation in skin infections prevalence is fuelling the growth of the macrolide antibiotics market.
What Segment Types Define the Macrolide Antibiotics Market Structure?
The macrolide antibioticsmarket covered in this report is segmented –
1) By Drugs: Azithromycin; Clarithromycin; Erythromycin; Fidaxomicin; Telithromycin
2) By Indication: Respiratory Tract Infections; Skin Infections; Sexually Transmitted Infections; Gastrointestinal Infections; Other Indications
3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Providers
5) By End User: Hospital; Dermatology Clinic; Clinic; Ambulatory Centre; Research Laboratories
Subsegments:
1) By Azithromycin: Oral Tablets; Oral Suspension; Injection
2) By Clarithromycin: Immediate-Release Tablets; Extended-Release Tablets; Oral Suspension
3) By Erythromycin: Tablets; Capsules; Topical Solution; Injection
4) By Fidaxomicin: Oral Tablets
5) By Telithromycin: Oral Tablets
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=16472&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Macrolide Antibiotics Market?
North America was the largest region in the macrolide antibiotics market in 2024. The regions covered in the macrolide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing theMacrolide Antibiotics Industry Evolution?
Prominent players in the macrolide antibiotic market are channeling their efforts into creating generic formulations to enhance accessibility, lower the cost of treatment and broaden their market presence. Generic versions of macrolide antibiotics are non-branded drugs that maintain the same active components, dosage, and potency as their original branded counterparts. For example, in May 2022, Phantom Pharmaceuticals, a pharmaceutical firm based in the US, introduced VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK, both developed for treating Helicobacter pylori (H. pylori) infection in adults. VOQUEZNA TRIPLE PAK comprises vonoprazan, a potassium-competitive acid blocker (PCAB), paired with amoxicillin and clarithromycin, whereas VOQUEZNA DUAL PAK is a blend of vonoprazan and amoxicillin. These therapies are ground-breaking as vonoprazan signifies the first fresh class of acid suppressants to gain approval in the U.S. in more than 30 years.
View the full report here:
https://www.thebusinessresearchcompany.com/report/macrolide-antibiotics-global-market-report
What Is the Definition of the Macrolide Antibiotics Market?
Macrolide antibiotics are a class of antibiotics characterized by a macrocyclic lactone ring with one or more sugars attached. They inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, making them effective against various Gram-positive and some Gram-negative bacteria.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16472
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model